Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus

被引:0
|
作者
Li, Shihong [1 ]
Li, Zhizhong [1 ]
Hou, Xuejian [1 ]
Sun, Junping [1 ]
Kang, Lihui [1 ]
Cheng, Yutong [1 ]
Tao, Ying [1 ]
Li, Zhao [1 ]
Chen, Xuanzu [1 ]
Zhang, Donghua [1 ]
Yan, Xianliang [1 ]
Wang, Su [1 ]
Gao, Yulong [1 ]
Wang, Qian [1 ]
Lin, Yun [1 ]
Yin, Chengqian [1 ]
Zhang, Jingmei [1 ]
Gao, Yun [1 ]
Huang, Ji [1 ]
Wu, Xiangyu [1 ]
Li, Nan [1 ]
Su, Wang [1 ]
Liu, Honghong [1 ]
Sun, Tao [1 ]
机构
[1] Capital Med Univ, Beijing Zhen Hosp, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
关键词
Diabetes mellitus; safety and cost; acute coronary syndrome; percutaneous coronary intervention; early discharge; hospitalization; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; SAME-DAY DISCHARGE; LENGTH-OF-STAY; HEART-DISEASE; CARDIOVASCULAR-ANGIOGRAPHY; ARTERY-DISEASE; IMPACT; REVASCULARIZATION; METAANALYSIS;
D O I
10.1177/0300060519842777
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective To evaluate the safety and cost of early discharge compared with ordinary discharge in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) for acute coronary syndrome. Methods We performed a retrospective analysis of prospectively collected data from 474 patients with DM who were discharged from hospital following PCI at a regional center between 2012 and 2015. Results A total of 192 patients (40.5%) were included in the early discharge group and 282 patients (59.5%) were included in the ordinary group. Mortality and morbidity after PCI were recorded. Kaplan-Meier analysis showed similar prognosis between the two groups at 30 days and at 1 year after discharge. However, hospitalization expenses for the regular discharge group were significantly higher than those of the early discharge group (RMB65,750 vs. RMB50,983). Conclusion Our findings demonstrate that early discharge of patients with DM following PCI for acute coronary syndrome is safe compared with ordinary discharge, and may reduce hospitalization costs.
引用
收藏
页码:3905 / 3917
页数:13
相关论文
共 50 条
  • [41] Risk factors of contrast-induced acute kidney injury in patients with acute coronary syndrome and diabetes mellitus undergoing emergency percutaneous coronary intervention
    Shi, Chao
    Zhou, Yujie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C187 - C188
  • [42] Acute coronary syndrome in young patients: frequency, mechanisms and clinical outcomes following percutaneous coronary intervention
    Zanchin, C.
    Ledwoch, S.
    Ueki, Y.
    Otsuka, T.
    Karagiannis, A.
    Losdat, S.
    Stortecky, S.
    Koskinas, K. C.
    Siontis, G. C. M.
    Praz, F.
    Billinger, M.
    Valgimigli, M.
    Pilgrim, T.
    Windecker, S.
    Raeber, L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3379 - 3379
  • [43] Anticoagulation Following Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Yousaf, Amman
    Ahsan, Muhammad J.
    Ahmad, Soban
    Latif, Azka
    Ahsan, Muhammad Zoraiz
    Qavi, Ahmed
    Ghali, Magdi G.
    Ardhanari, Sivakumar
    Goldsweig, Andrew M.
    CIRCULATION, 2023, 148
  • [44] Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients
    Martinez, Gonzalo J.
    Barraclough, Jennifer Y.
    Nakhla, Shirley
    Kienzle, Vivian
    Robertson, Stacy
    Mallat, Ziad
    Celermajer, David S.
    Patel, Sanjay
    BIOSCIENCE REPORTS, 2017, 37
  • [45] Cost-effectiveness of Radial Access Percutaneous Coronary Intervention in Acute Coronary Syndrome
    Lee, Peter
    Liew, Danny
    Brennan, Angela
    Stub, Dion
    Lefkovits, Jeffrey
    Reid, Christopher M.
    Zomer, Ella
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 156 : 44 - 51
  • [46] Biomarkers in acute coronary syndrome and percutaneous coronary intervention
    Searle, J.
    Danne, O.
    Mueller, C.
    Mockel, M.
    MINERVA CARDIOANGIOLOGICA, 2011, 59 (03): : 203 - 223
  • [47] OUTCOMES ANALYSIS OF FEMALE OCTOGENARIAN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERWENT PERCUTANEOUS CORONARY INTERVENTION
    Ma Hanying
    Han Hong-ya
    Yang Qing
    Nie-Bin
    Liu Rui-fang
    Chai Meng
    Zhang Ou
    Guo Wen
    Zhou Yu-jie
    HEART, 2013, 99 : E166 - E166
  • [48] Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Zhang, Yahao
    Zhang, Yanghui
    Zhang, Bin
    Chen, Zheng
    Wei, Yongjie
    Chen, Penglei
    Chang, Chao
    Liu, Guizhi
    Chen, Kui
    Ding, Jiandong
    Jiang, Zhengming
    CLINICAL THERAPEUTICS, 2022, 44 (06) : 901 - 912
  • [49] Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
    Xiaoteng Ma
    Lisha Dong
    Qiaoyu Shao
    Yujing Cheng
    Sai Lv
    Yan Sun
    Hua Shen
    Zhijian Wang
    Yujie Zhou
    Xiaoli Liu
    Cardiovascular Diabetology, 19
  • [50] Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
    Ma, Xiaoteng
    Dong, Lisha
    Shao, Qiaoyu
    Cheng, Yujing
    Lv, Sai
    Sun, Yan
    Shen, Hua
    Wang, Zhijian
    Zhou, Yujie
    Liu, Xiaoli
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)